In the last trading session, 1.64 million shares of the Transmedics Group Inc (NASDAQ:TMDX) were traded, and its beta was 2.14. Most recently the company’s share price was $69.11, and it changed around -$0.22 or -0.32% from the last close, which brings the market valuation of the company to $2.33B. TMDX currently trades at a discount to its 52-week high of $177.37, offering almost -156.65% off that amount. The share price’s 52-week low was $55.00, which indicates that the current value has risen by an impressive 20.42% since then.
Transmedics Group Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.70. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 3 recommended TMDX as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Transmedics Group Inc is expected to report earnings per share of 0.24 for the current quarter.
Transmedics Group Inc (NASDAQ:TMDX) trade information
Instantly TMDX has showed a red trend with a performance of -0.32% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 80.22 on recent trading dayincreased the stock’s daily price by 13.85%. The company’s shares are currently up 10.84% year-to-date, but still down -5.33% over the last five days. On the other hand, Transmedics Group Inc (NASDAQ:TMDX) is 2.31% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $109, which translates to bulls needing to increase their stock price by 36.6% from its current value. Analyst projections state that TMDX is forecast to be at a low of $90 and a high of $125.
Transmedics Group Inc (TMDX) estimates and forecasts
The year-over-year growth rate is expected to be 22.34%, up from the previous year.
Consensus estimates provided by 7 financial analysts predict the company will bring in an average of 123.4M in revenue for the current quarter. 7 analysts expect Transmedics Group Inc to make 132.51M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 96.85M and 114.31M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 27.41%. Forecasts for the next quarter put sales growth at 15.93%.
Transmedics Group Inc earnings are expected to increase by 45.05% in 2025, but the outlook is positive 43.13% per year for the next five years.
TMDX Dividends
Transmedics Group Inc’s next quarterly earnings report is expected to be released in April.
BLACKROCK INC., with 8.0755% or 2.65 million shares worth $398.47 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 2.17 shares worth $149.98 million, making up 6.45% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 1.02 shares worth around $70.46 million, which represents about 3.03% of the total shares outstanding.
